Are expensive vaccines the best investment in lower-middle income countries?

Lone Simonsen, Maarten van Wijhe, Robert J. Taylor

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

OriginalsprogEngelsk
TidsskriftThe Lancet Global Health
Vol/bind7
Udgave nummer5
Sider (fra-til)E548-E549
Antal sider2
ISSN2214-109X
DOI
StatusUdgivet - 1 maj 2019

Citer dette

@article{c6f135888b3c41b18ea02366f163965c,
title = "Are expensive vaccines the best investment in lower-middle income countries?",
author = "Lone Simonsen and Wijhe, {Maarten van} and Taylor, {Robert J.}",
note = "Invited commentary",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/S2214-109X(19)30040-3",
language = "English",
volume = "7",
pages = "E548--E549",
journal = "The Lancet Global Health",
issn = "2214-109X",
publisher = "The Lancet Publishing Group",
number = "5",

}

Are expensive vaccines the best investment in lower-middle income countries? / Simonsen, Lone; Wijhe, Maarten van; Taylor, Robert J.

I: The Lancet Global Health, Bind 7, Nr. 5, 01.05.2019, s. E548-E549.

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

TY - JOUR

T1 - Are expensive vaccines the best investment in lower-middle income countries?

AU - Simonsen, Lone

AU - Wijhe, Maarten van

AU - Taylor, Robert J.

N1 - Invited commentary

PY - 2019/5/1

Y1 - 2019/5/1

U2 - 10.1016/S2214-109X(19)30040-3

DO - 10.1016/S2214-109X(19)30040-3

M3 - Comment/debate

VL - 7

SP - E548-E549

JO - The Lancet Global Health

JF - The Lancet Global Health

SN - 2214-109X

IS - 5

ER -